MoneyWorks4Me

Lasa Supergenerics informs about postponement of board meeting

07 Jun 2023 Evaluate

Pursuant to Regulations 29 and Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to its update dated May 27, 2023, Lasa Supergenerics has informed that Board Meeting which was supposed to be held today has been rescheduled to Friday June 09, 2023, since the consolidation of books of Harishree Aromatics and Chemicals on account of Amalgamation could not be completed on time.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..